{"id":413709,"date":"2019-07-25T08:02:01","date_gmt":"2019-07-25T08:02:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=413709"},"modified":"2019-07-25T08:02:01","modified_gmt":"2019-07-25T08:02:01","slug":"biopharmaceuticals-market-projected-to-grasp-526008-million-by-2025-with-a-cagr-138-allied-market-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biopharmaceuticals-market-projected-to-grasp-526008-million-by-2025-with-a-cagr-138-allied-market-research_413709.html","title":{"rendered":"Biopharmaceuticals Market Projected to Grasp $526,008 Million by 2025 With a CAGR 13.8% – Allied Market Research"},"content":{"rendered":"
\"Biopharmaceuticals<\/a><\/p>\n
\n
Biopharmaceuticals Market <\/div>\n<\/div>\n<\/div>\n
Pharmaceutical companies have streamlined drug discovery and development through adoption of biopharmaceuticals. Biopharmaceuticals and therapeutic proteins have immensely aided in target-based treatment for chronic diseases, especially cancer<\/div>\n

According to a new report released by Allied Market Research, according to “Biopharmaceutical market<\/a> by type and application: Global opportunity analysis and industry forecast, 2018-2025”, the market is $186,470 million in 2017, and is anticipated to hit $526,008 million In 2025, the growth rate is 13.8% CAGR from 2018 to 2025. North America is expected to be the highest revenue contributor throughout the forecast period.<\/p>\n

Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.<\/p>\n

Request Sample Report at:<\/strong> https:\/\/www.alliedmarketresearch.com\/request-sample\/3971<\/a><\/p>\n

The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in elderly population, and upsurge in prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.<\/p>\n

By type, the monoclonal antibody segment accounted for nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for one-third share in 2017, and is projected to exhibit a prominent growth rate, owing to surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.<\/p>\n

For Purchase Enquiry:<\/strong> https:\/\/www.alliedmarketresearch.com\/purchase-enquiry\/3971<\/a><\/p>\n

KEY FINDINGS OF THE STUDY<\/strong> <\/p>\n